Thomas Römer

ORCID: 0000-0001-5241-8095 · 49 papers in corpus
case-report 2020
·doi:10.23937/2377-9004/1410166

Adenomyosis refers to the occurrence of ectopic endometrial glands and the surrounding stroma within the myometrium. A distinction is made between diffuse and focal forms (rare nodular forms and an adenomyoma). Ectopic pregnancy (EUG) occur…

observational 2020
Archives of gynecology and obstetrics ·doi:10.1007/s00404-020-05750-9

INTRODUCTION: It is suspected that uterine malformations and endometriosis have a high coincidence. Furthermore, it is expected that obstructive uterine malformations are significantly higher affected than non-obstructive malformations. The…

case-report 2020
·doi:10.1055/s-0040-1718359

Wir präsentieren den Fall einer 33-jährigen Frau GII / PI, die sich in der 6. Schwangerschaftswoche bei einer vaginalen Blutung vorstellte. Die nächste Vorstellung erfolgte in 7 + 3 SSW aufgrund der wehenartigen Unterbauchschmerzen sowie da…

review 2020
Drugs in context ·doi:10.7573/dic.2020-10-1

Optimizing menopausal hormone therapy (MHT) requires an awareness of the benefits and risks associated with the available treatments. This narrative review, which is based on the proceedings of an Advisory Board meeting and supplemented by …

review 2020
Current medical research and opinion ·doi:10.1080/03007995.2020.1744120

Objective: Endometriosis affects up to 10% of women of reproductive age, and the main goal of treatment is to relieve symptoms. Progestins have been the mainstay of endometriosis suppression, of which dienogest has become an important optio…

other 2018
Archives of gynecology and obstetrics ·doi:10.1007/s00404-018-4977-0

In the original publication of the article, the word laparotomy has been presented in the proofs instead of laparoscopy in the below places.

other 2018
Archives of gynecology and obstetrics ·doi:10.1007/s00404-018-4864-8

PURPOSE: Endometriosis is a debilitating disease with high recurrence rates requiring long-term management. Progestins such as dienogest are used empirically when first symptoms occur and post-surgery to reduce recurrence. This retrospectiv…

review 2016
Deutsches Arzteblatt international ·doi:10.3238/arztebl.2016.0242

BACKGROUND: Hysterectomy is the second most common operation in obstetrics and gynecology after Cesarean section. Until now, there has not been any German clinical guideline with recommendations concerning the indications for hysterectomy f…

rct 2014
International Journal of Gynecology & Obstetrics ·doi:10.1016/j.ijgo.2013.11.017

OBJECTIVE: To demonstrate the superiority of estradiol valerate plus dienogest (E(2)V/DNG) over ethinylestradiol plus levonorgestrel (EE/LNG) in reducing the number of days with dysmenorrheic pain among women with primary dysmenorrhea. MET…

review 2012
Medizinische Monatsschrift fur Pharmazeuten

Endometriosis is one of the frequent gynecological diseases in premenopausal women. The clinical diagnostics is difficult because symptoms of endometriosis are variable. The surgical removal of endometriosis is the primary therapeutic aim. …

rct 2011
Human Reproduction ·doi:10.1093/humrep/der224

BACKGROUND: This double-blind trial investigated the efficacy and safety of estradiol valerate/dienogest (E(2)V/DNG) for the treatment of heavy menstrual bleeding without recognizable organic pathology. METHODS: Otherwise healthy women wit…

rct 2009
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2009.11.001

OBJECTIVE: A novel oral contraceptive (OC) that contains oestradiol valerate (E2V; 1 mg of E2V is equivalent to 0.76 mg of 17beta-oestradiol) and dienogest (DNG) has been developed. The efficacy and safety of this formulation was assessed i…

2008

In Europa wird die Idee der Qualitätsverbesserung auf dem Gebiet der Endometriose vertieft. Verschiedene "Task Forces" arbeiten mit zum Teil identischen Methoden am gleichen Ziel. Die Bildung spezialisierter Endometriosezentren verbunden mi…

rct 2001
Climacteric : the journal of the International Menopause Society ·doi:10.1080/713605132

OBJECTIVE: To evaluate the efficacy, safety and tolerability of continuous combined hormone replacement therapy (HRT) with Climodien (estradiol valerate 2 mg plus dienogest 2 mg). DESIGN: Open, multinational, multicenter, non-controlled ph…

nonrandomized-trial 2001
·doi:10.1080/cmt.4.4.332.342

Objective To evaluate the efficacy, safety and tolerability of continuous combined hormone replacement therapy (HRT) with Climodien® (estradiol valerate 2 mg plus dienogest 2 mg). Design Open, multinational, multicenter, non-controlled phas…

other 2001
European Journal of Obstetrics & Gynecology and Reproductive Biology ·doi:10.1016/s0301-2115(01)00460-2

OBJECTIVES: The aim of our study was to investigate the role of the intact endometrium and ovaries for serum levels of insulin-like growth factor binding protein-1 (IGFBP-1) and glycodelin. STUDY DESIGN: In 35 premenopausal patients with a…

rct 2001
Gynecologic and obstetric investigation ·doi:10.1159/000052970

Transvaginal hydrolaparoscopy (THL) was evaluated in comparison with the already established chromolaparoscopy in the detection of tubal factors, adhesions as well as endometriosis. 43 infertile patients without previous pelvic operations a…

2000
·doi:10.1016/s0020-7292(00)81476-9
review 2000
Contributions to gynecology and obstetrics ·doi:10.1159/000060283

Hysteroscopic surgery is widely used for the treatment of patients suffering from infertility and menorrhagia. Preoperative and postoperative treatment plays an important role in this kind of surgery. The indications for hormonal pre- and p…

other 1999
Gynecologic and obstetric investigation ·doi:10.1159/000010117

If bleeding disorders, which could not be treated by modification of steroid dosages, occurred during sequential hormone replacement therapy (HRT), most of the patients stopped HRT. In these cases a diagnostic outpatient hysteroscopy with b…

nonrandomized-trial 1997
European Journal of Obstetrics & Gynecology and Reproductive Biology ·doi:10.1016/s0301-2115(97)00103-6

OBJECTIVE: To determine the best pretreatment of the endometrium prior to roller ball endometrial ablation. STUDY DESIGN: Forty patients with recurrent hypermenorrhea underwent diagnostic hysteroscopy and dilation and curettage. They were …

other 1996
Zentralblatt für Gynäkologie

The use of a 1.2 mm microendoscope is compared to the conventional laparoscopy technique in this study. In 22 sterility patients and 23 patients suffering from chronic pelvic pain the high diagnostic value of the microendoscope is shown. On…

rct 1996
Zentralblatt für Gynäkologie

In a prospective study in 40 patients the pretreatment for endometrial ablation with a gestagen (Orgametril 10 mg/die), danazol (600 mg/die) and an injection of a GnRH-analogon (Decapeptyl-Depot) was compared with a control group without pr…

case-report 1995

13 months after a hysteroscopic endometrial ablation a haematometra was diagnosed in a 44 year-old women as a source of recurrent pelvic pain. The cause of the haematometra was a complete obliteration of the ostium cervicae internum. This l…